Fresenius SE & Co. (OTCMKTS:FSNUY) Share Price Crosses Below Fifty Day Moving Average – Should You Sell?

Posted by Mark Dietrich on May 23rd, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report)’s share price passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $12.57 and traded as low as $11.58. Fresenius SE & Co. shares last traded at $11.83, with a volume of 72,340 shares.

Wall Street Analyst Weigh In

A number of equities analysts have commented on FSNUY shares. Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a research note on Monday, April 20th. Citigroup reissued a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company presently has an average rating of “Buy”.

Check Out Our Latest Report on Fresenius SE & Co.

Fresenius SE & Co. Trading Down 4.0%

The company has a market cap of $25.62 billion, a price-to-earnings ratio of 15.16 and a beta of 0.68. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.32 and a quick ratio of 1.00. The business has a 50 day simple moving average of $12.48 and a 200 day simple moving average of $13.76.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). The firm had revenue of $6.75 billion for the quarter, compared to the consensus estimate of $6.79 billion. Fresenius SE & Co. had a return on equity of 10.29% and a net margin of 6.55%. As a group, equities analysts forecast that Fresenius SE & Co. will post 1.05 EPS for the current year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.